Rona Therapeutics
PrivateLast Round
Series A
Extension
Jul 19, 2024
Total Funding Raised
$68M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rona Therapeutics is a biotechnology company that develops an RNA therapeutics platform designed for RNA medicine discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rona Therapeutics Comparables
Compare Rona Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argo Biopharma | 89% | |
| Visirna Therapeutics | 88% | |
| Sirius Therapeutics, Inc. | 86% | |
Rona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 19, 2024 | ||||
| Series A | Apr 7, 2022 |
Rona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longriver Investment Partners | Series A Extension |
| BioTrack Capital | Series A Extension |
| 招银国际金融有限公司 | Series A |
| Lapam Capital | Series A, Series A Extension |
| Platanus Ventures | Series A |
| LongRiver Investments | Series A Extension |
| Lilly Asia Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 117% MoM, reaching 3.6K.
- Jan 6, 2026
Monthly visitors increased 2227% MoM, reaching 7.5K.
Rona Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rona Therapeutics's valuation, stock price, and market status.